Hansoh Pharmaceutical Group Company Limited Overview
Pro stress-test →Hansoh Pharmaceutical Group is an investment holding company engaged in the research, development, production, and sale of pharmaceutical products in the People's Republic of China, providing products for therapeutic areas including anti-infection, central nervous system, oncology, and metabolic and autoimmune diseases. The company is the largest psychotropic drug producer in China.
Strategic Profile
Pro stress-test →Hansoh is a research and development-driven pharmaceutical company holding a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. The company is building a sustainable profit engine through overseas out-licensing deals, including a blockbuster deal with MSD for an oral small molecule GLP-1R agonist.
Competitive Landscape
Pro stress-test →Direct competitors in the Chinese pharmaceutical space include Shanghai Fosun Pharmaceutical Group and China Traditional Chinese Medicine Holdings. Hansoh differentiates through its focus on innovative drugs with global partnership potential and strong domestic CNS/oncology franchises.
Industry Context
Hansoh Pharmaceutical Group Company Limited operates in Pharmaceutical Manufacturing - Specialty & Generic.
Key facts
Founded: 1995 · Headquarters: Shanghai, China · Employees: 9,313 · Revenue: $1.75B USD (RMB 12.26B FY24) · Market cap: $28.9B HKD